All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @newtonbuilt on TikTok · 15s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @newtonbuilt's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00It's a bad thing.
  2. 0:02Oh fuck.
  3. 0:04What's going to happen now?
  4. 0:05Oh fuck.
  5. 0:06I just hit a vein, bro.
  6. 0:08That's by the way the probability of being a vane is super unlikely.
  7. 0:12And I just fucking hit a vein.

@newtonbuilt's testosterone therapy claims, fact-checked

newtonbuilt

TikTok creator

2.8M viewsWatch on TikTok

Quick answer

The video captures an apparent inadvertent intravascular event during self-injection of what is presumed to be an oil-based testosterone preparation, likely cypionate or enanthate. Pulmonary oil microembolism (POME) is a documented adverse event in this context, presenting with respiratory symptoms within minutes of injection. Anyone self-administering oil-based testosterone who experiences immediate coughing, chest tightness, or lightheadedness post-injection should contact their prescribing provider or seek urgent care.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @newtonbuilt's testosterone therapy claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@newtonbuilt's testosterone therapy claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@newtonbuilt's testosterone therapy claims, fact-checked" from newtonbuilt. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video captures an apparent inadvertent intravascular event during self-injection of what is presumed to be an oil-based testosterone preparation, likely cypionate or enanthate.

The reason this review is not generic is the source wording and the canonical claim label "trt tiktok 7584776284048477460." In this clip, the useful excerpt is: "It's a bad thing." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The WHO removed routine pre-injection aspiration from its 2015 guidelines because vascular placement at typical IM sites (gluteal, vastus lateralis, deltoid) is uncommon enough that aspiration provided no meaningful safety benefit.
People who land here are usually trying to understand whether the Testosterone claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video captures an apparent inadvertent intravascular event during self-injection of what is presumed to be an oil-based testosterone preparation, likely cypionate or enanthate.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video captures an apparent inadvertent intravascular event during self-injection of what is presumed to be an oil-based testosterone preparation, likely cypionate or enanthate. Pulmonary oil microembolism (POME) is a documented adverse event in this context, presenting with respiratory symptoms within minutes of injection. Anyone self-administering oil-based testosterone who experiences immediate coughing, chest tightness, or lightheadedness post-injection should contact their prescribing provider or seek urgent care.
  • Inadvertent intravascular injection during IM testosterone administration occurs in under 2% of injections at standard sites, according to clinical injection technique literature.
  • The WHO removed routine pre-injection aspiration from its 2015 guidelines because vascular placement at typical IM sites (gluteal, vastus lateralis, deltoid) is uncommon enough that aspiration provided no meaningful safety benefit.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Inadvertent intravascular injection during IM testosterone administration occurs in under 2% of injections at standard sites, according to clinical injection technique literature.
  • The WHO removed routine pre-injection aspiration from its 2015 guidelines because vascular placement at typical IM sites (gluteal, vastus lateralis, deltoid) is uncommon enough that aspiration provided no meaningful safety benefit.
  • Oil-based testosterone formulations (cypionate, enanthate) carry a specific risk called pulmonary oil microembolism (POME) if injected intravascularly. Lunning et al. (2014, JAMA Internal Medicine) documented real cases with respiratory symptoms.
  • Warning signs of POME include immediate coughing, chest tightness, shortness of breath, or near-fainting within minutes of injection. These require prompt medical contact, not observation.
  • Subcutaneous injection of testosterone has been studied as an alternative with comparable pharmacokinetics and near-zero vascular placement risk. Spratt et al. (2021, Journal of Clinical Endocrinology and Metabolism) found similar absorption profiles.
  • Self-injecting testosterone without clinical oversight removes the safety layer that catches and responds to adverse events like this one. A telehealth or in-person prescriber relationship is a documented harm-reduction factor, not a bureaucratic obstacle.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @newtonbuilt actually say?

On camera, mid-injection, @newtonbuilt told his 2.8 million viewers he had just hit a vein, then immediately said hitting a vein is "super unlikely." That's the entire claim, compressed into a moment of visible panic. It's actually a two-part statement: something bad just happened, and also that thing almost never happens. Both halves deserve scrutiny.

To his credit, he didn't catastrophize or give dangerous follow-up advice. He didn't tell people to push through a vein strike, change the dose, or do anything reckless. He just reacted, labeled it rare, and moved on. That restraint matters in a 2.8 million view context.

Does the science back this up?

Yes, mostly. Inadvertent intravascular injection during intramuscular (IM) injection is genuinely uncommon, and the data supports calling it unlikely. The mechanism that makes it rare is anatomical: the gluteal, vastus lateralis, and deltoid sites used for testosterone injections sit in muscular tissue with relatively small-caliber vessels, not major veins.

A 2015 systematic review by Nicoll and Hesby in the Journal of Infusion Nursing found that aspiration before IM injection, historically used to check for vein entry, was not evidence-based and has largely been abandoned in clinical guidelines, precisely because vascular placement at standard IM sites is uncommon enough that the practice added no meaningful safety benefit. The World Health Organization formally recommended against routine aspiration for most IM sites in 2015.

That said, "super unlikely" doesn't mean impossible, as @newtonbuilt just demonstrated live. Estimated rates of inadvertent intravascular injection at IM sites range from less than 1% to around 2% depending on technique, needle length, and injection site.

What did they get wrong (or right)?

He got the core fact right: hitting a vein during a standard intramuscular testosterone injection is a low-probability event. The literature supports this. Where the video falls short is what it doesn't say, which matters a lot given the audience size.

What actually happens when you do hit a vein during a testosterone injection? The risk isn't bleeding out. The real concern is oil embolism. Testosterone cypionate and enanthate are suspended in carrier oils, typically cottonseed or sesame. If that oil gets pushed into a vein, it can travel to the lungs. Case reports of pulmonary oil microembolism (POME) from intravascular testosterone injection exist in the literature. Lunning et al. (2014, JAMA Internal Medicine) documented POME cases presenting with coughing, chest tightness, and dizziness within minutes of injection.

The tell-tale sign he didn't mention: if you aspirate blood into the syringe, or if you get a sudden cough, chest pain, or feel faint immediately after injecting, those are red flags that warrant stopping and seeking care. A passing "oh fuck" doesn't cover that ground.

What should you actually know?

If you inject testosterone at home, here is what the evidence actually recommends. First, hitting a vein during a proper IM injection is uncommon, under 2% in most estimates, and @newtonbuilt is right about that. Second, the consequences when it does happen are not trivial. Oil embolism from oil-based testosterone injections is a documented, real adverse event, not a scare tactic.

Current clinical guidance from the Endocrine Society (2018 clinical practice guidelines) recommends standard IM injection technique at validated sites. Many clinicians have moved to subcutaneous injection for testosterone, which carries essentially zero vascular placement risk and has shown comparable pharmacokinetics for depot formulations (Spratt et al., 2021, Journal of Clinical Endocrinology and Metabolism).

Signs of possible pulmonary oil microembolism include immediate or near-immediate coughing, chest discomfort, shortness of breath, or feeling faint after injection. If those occur, stop the injection immediately and contact a medical provider. This is not a "walk it off" situation. If you are self-injecting testosterone without clinical supervision, this video is a good reminder that a telehealth provider relationship is not optional, it is a safety layer.

The bottom line

@newtonbuilt's offhand claim that hitting a vein is "super unlikely" during a testosterone injection is accurate by the numbers. The problem is what he didn't say: when it does happen with an oil-based hormone preparation, there's a documented path to pulmonary complications. A 2.8 million view moment of panic deserved a 30-second explanation. It didn't get one.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

newtonbuilt · TikTok creator

2.8M views on this video

@newtonbuilt's testosterone therapy claims, fact-checked

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about inadvertent intravascular injection during im testosterone administration occurs in under?

Inadvertent intravascular injection during IM testosterone administration occurs in under 2% of injections at standard sites, according to clinical injection technique literature.

What does the video say about the who removed routine pre-injection aspiration from its 2015 guidelines?

The WHO removed routine pre-injection aspiration from its 2015 guidelines because vascular placement at typical IM sites (gluteal, vastus lateralis, deltoid) is uncommon enough that aspiration provided no meaningful safety benefit.

What does the video say about oil-based testosterone formulations (cypionate, enanthate) carry a specific risk called?

Oil-based testosterone formulations (cypionate, enanthate) carry a specific risk called pulmonary oil microembolism (POME) if injected intravascularly. Lunning et al. (2014, JAMA Internal Medicine) documented real cases with respiratory symptoms.

What does the video say about warning signs of pome include immediate coughing, chest tightness, shortness?

Warning signs of POME include immediate coughing, chest tightness, shortness of breath, or near-fainting within minutes of injection. These require prompt medical contact, not observation.

What does the video say about subcutaneous injection of testosterone has been studied as an alternative?

Subcutaneous injection of testosterone has been studied as an alternative with comparable pharmacokinetics and near-zero vascular placement risk. Spratt et al. (2021, Journal of Clinical Endocrinology and Metabolism) found similar absorption profiles.

What does the video say about self-injecting testosterone without clinical oversight removes the safety layer?

Self-injecting testosterone without clinical oversight removes the safety layer that catches and responds to adverse events like this one. A telehealth or in-person prescriber relationship is a documented harm-reduction factor, not a bureaucratic obstacle.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by newtonbuilt, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.